Higher risk of chronic kidney disease and progressive kidney function impairment in primary aldosteronism than in essential hypertension. Case-control study-Reference-Cited by-同舟云学术

Higher risk of chronic kidney disease and progressive kidney function impairment in primary aldosteronism than in essential hypertension. Case-control study

Published:2021-04-02 Issue:2 Volume:73 Page:439-446
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Fernández-Argüeso María,Pascual-Corrales Eider,Bengoa Rojano Nuria,García Cano Ana,Jiménez Mendiguchía Lucía,Araujo-Castro Marta^ORCID

Funder

SENDIMAD

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s12020-021-02704-2.pdf

Reference41 articles.

1. M. Araujo-castro, Tratamiento del hiperaldosteronismo primario. Med Clin. 22, S0025-7753(20)30323-7 (2020). https://doi.org/10.1016/j.medcli.2020.04.029

2. J.W. Funder, R.M. Carey, F. Mantero, M.H. Murad, M. Reincke, H. Shibata et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101(5), 1889–1916 (2016). https://doi.org/10.1210/jc.2015-4061

3. P. Milliez, X. Girerd, P.F. Plouin, J. Blacher, M.E. Safar, J.J. Mourad, Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J. Am. Coll. Cardiol. 45(8), 1243–1248 (2005). https://doi.org/10.1016/j.jacc.2005.01.015

4. G.P. Rossi, M. Boscaro, V. Ronconi, J.W. Funder, Aldosterone as a cardiovascular risk factor. Trends Endocrinol. Metab. 16(3), 104–107 (2005). https://doi.org/10.1016/j.tem.2005.02.010

5. Z. Šomlóová, J. Widimský, J. Rosa, D. Wichterle, B. Štrauch, O. Petrák et al. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism. J. Hum. Hypertens. 24(10), 625–630 (2010). https://doi.org/10.1038/jhh.2010.65.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary aldosteronism prevalence enhanced by strict adherence to 2016 Endocrine Society guidelines: insights from an endocrine hypertension unit;Journal of Hypertension;2024-07-24

2. Impact of primary aldosteronism on kidney function: results from the SPAIN-ALDO registry;Journal of Hypertension;2024-07-05

3. Primary aldosteronism: An underdiagnosed clinical entity;Journal of Current Cardiology;2024-05

4. Feasibility of primary aldosteronism diagnosis in initial evaluation without medication withdrawal or confirmatory tests;Endocrine;2024-04-03

5. Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism;Endocrine;2024-03-06